Scedosporium boydii CatA1 and SODC recombinant proteins, new tools for serodiagnosis of Scedosporium infection of patients with cystic fibrosis
- 1 December 2017
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 89 (4) , 282-287
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Toward the Standardization of Mycological Examination of Sputum Samples in Cystic Fibrosis: Results from a French Multicenter Prospective StudyMycopathologia, 2017
- Novel immunologic classification of aspergillosis in adult cystic fibrosisJournal of Allergy and Clinical Immunology, 2013
- Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular MethodsAntimicrobial Agents and Chemotherapy, 2012
- Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungiMedical Mycology, 2010
- Clinical associations and prevalence ofScedosporiumspp. in Australian cystic fibrosis patients: identification of novel risk factors?Medical Mycology, 2010
- Infections Caused byScedosporiumsppClinical Microbiology Reviews, 2008
- Prevalence and Susceptibility Testing of New Species of Pseudallescheria and Scedosporium in a Collection of Clinical Mold IsolatesAntimicrobial Agents and Chemotherapy, 2007
- Pseudallescheria boydii (Anamorph Scedosporium apiospermum) Infection in Solid Organ Transplant Recipients in a Tertiary Medical Center and Review of the LiteratureMedicine, 2002
- Genotyping Study of Scedosporium apiospermum Isolates from Patients with Cystic FibrosisJournal of Clinical Microbiology, 2002
- Clinical Significance of Scedosporium apiospermum in Patients with Cystic FibrosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2000